SEHK Growth Companies With High Insider Ownership To Watch

Amid a backdrop of fluctuating global markets, the Hong Kong stock market has shown resilience, with particular interest in growth companies that boast high insider ownership. Such firms often demonstrate a strong alignment between management’s interests and shareholder value, a quality that can be particularly appealing in uncertain economic times.

Top 10 Growth Companies With High Insider Ownership In Hong Kong

Name	Insider Ownership	Earnings Growth
iDreamSky Technology Holdings (SEHK:1119)	20.2%	104.1%
Pacific Textiles Holdings (SEHK:1382)	11.2%	37.7%
Tian Tu Capital (SEHK:1973)	34%	70.5%
Adicon Holdings (SEHK:9860)	22.4%	28.3%
Zhejiang Leapmotor Technology (SEHK:9863)	15%	73.4%
DPC Dash (SEHK:1405)	38.2%	91%
Zylox-Tonbridge Medical Technology (SEHK:2190)	18.7%	79.3%
Biocytogen Pharmaceuticals (Beijing) (SEHK:2315)	13.9%	100.1%
Beijing Airdoc Technology (SEHK:2251)	28.7%	83.9%
Ocumension Therapeutics (SEHK:1477)	23.3%	93.7%

Click here to see the full list of 53 stocks from our Fast Growing SEHK Companies With High Insider Ownership screener.

Here we highlight a subset of our preferred stocks from the screener.

iDreamSky Technology Holdings (SEHK:1119)

Simply Wall St Growth Rating: ★★★★★★

Overview: iDreamSky Technology Holdings Limited is an investment holding company that operates a digital entertainment platform in China, publishing games through mobile apps and websites, with a market cap of approximately HK$3.86 billion.

Operations: The company generates revenue primarily from its Game and Information Services segment, totaling CN¥1.92 billion.

Insider Ownership: 20.2%

Earnings Growth Forecast: 104.1% p.a.

iDreamSky Technology Holdings is poised for significant growth, with earnings expected to surge by 104.11% annually. The firm's revenue growth, at 29.8% per year, outpaces the Hong Kong market significantly. Insider activity reinforces this positive outlook, as more shares have been bought than sold by insiders recently. Additionally, the stock trades at a substantial discount of 37.3% below its estimated fair value, highlighting potential undervalued status despite high insider confidence and robust growth forecasts.

• Click here to discover the nuances of iDreamSky Technology Holdings with our detailed analytical future growth report.
• Our comprehensive valuation report raises the possibility that iDreamSky Technology Holdings is priced lower than what may be justified by its financials.

Xiamen Yan Palace Bird's Nest Industry (SEHK:1497)

Simply Wall St Growth Rating: ★★★★☆☆

Overview: Xiamen Yan Palace Bird's Nest Industry Co., Ltd. operates in the People’s Republic of China, focusing on the research, development, production, and marketing of edible bird’s nest products, with a market capitalization of approximately HK$6.60 billion.

Operations: The company generates revenue through various channels, including sales to online distributors (CN¥16.75 million), offline distributors (CN¥509.04 million), direct sales to online customers (CN¥824.40 million), offline customers (CN¥351.17 million), and e-commerce platforms (CN¥262.89 million).

Insider Ownership: 26.7%

Earnings Growth Forecast: 14.8% p.a.

Xiamen Yan Palace Bird's Nest Industry Co., Ltd. is experiencing a mixed financial trajectory with its revenue forecast to grow by 12.5% annually, outpacing the Hong Kong market average of 7.8%. However, the company anticipates a significant drop in net profit by up to 50% for the first half of 2024 compared to the previous year. Despite this downturn, insider ownership remains stable with no substantial buying or selling reported in the last three months, suggesting continued confidence from those closest to the company.

• Click to explore a detailed breakdown of our findings in Xiamen Yan Palace Bird's Nest Industry's earnings growth report.
• Our comprehensive valuation report raises the possibility that Xiamen Yan Palace Bird's Nest Industry is priced higher than what may be justified by its financials.

Adicon Holdings (SEHK:9860)

Simply Wall St Growth Rating: ★★★★★☆

Overview: Adicon Holdings Limited, with a market cap of HK$6.63 billion, operates medical laboratories across the People’s Republic of China.

Operations: The company generates CN¥3.30 billion from its healthcare facilities and services segment.

Insider Ownership: 22.4%

Earnings Growth Forecast: 28.3% p.a.

Adicon Holdings, a growth-oriented company in Hong Kong, has recently initiated a substantial share repurchase program, signaling confidence in its future prospects. The firm's revenue is expected to grow at 14.3% annually, surpassing the local market's 7.8% growth rate. Additionally, earnings are projected to increase significantly by 28.3% per year. However, it's worth noting that profit margins have declined from last year’s 14% to 7.1%. The recent appointment of Mr. ZHOU Mintao as chairman of the strategy committee may influence strategic directions positively.

• Navigate through the intricacies of Adicon Holdings with our comprehensive analyst estimates report here.
• Our expertly prepared valuation report Adicon Holdings implies its share price may be too high.

Where To Now?

• Take a closer look at our Fast Growing SEHK Companies With High Insider Ownership list of 53 companies by clicking here.
• Hold shares in these firms? Setup your portfolio in Simply Wall St to seamlessly track your investments and receive personalized updates on your portfolio's performance.
• Invest smarter with the free Simply Wall St app providing detailed insights into every stock market around the globe.

Want To Explore Some Alternatives?

• Explore high-performing small cap companies that haven't yet garnered significant analyst attention.
• Diversify your portfolio with solid dividend payers offering reliable income streams to weather potential market turbulence.
• Find companies with promising cash flow potential yet trading below their fair value.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.The analysis only considers stock directly held by insiders. It does not include indirectly owned stock through other vehicles such as corporate and/or trust entities. All forecast revenue and earnings growth rates quoted are in terms of annualised (per annum) growth rates over 1-3 years.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com